232 Chapter 9 86. Hsu YY, Chang CN, Jung SM, et al. Blood Oxygenation Level-Dependent MRI of Cerebral Gliomas during Breath Holding. Journal of Magnetic Resonance Imaging 2004; 19: 160–167. 87. Bright MG, Murphy K. Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance. Neuroimage 2013; 83: 559– 568. 88. Kastrup A, Li TQ, Glover GH, et al. Cerebral blood flow-related signal changes during breath-holding. American Journal of Neuroradiology 1999; 20: 1233–1238. 89. Magon S, Basso G, Farace P, et al. Reproducibility of BOLD signal change induced by breath holding. Neuroimage 2009; 45: 702–712. 90. Sleight E, Stringer MS, Marshall I, et al. Cerebrovascular Reactivity Measurement Using Magnetic Resonance Imaging: A Systematic Review. Frontiers in Physiology; 12. Epub ahead of print 25 February 2021. DOI: 10.3389/fphys.2021.643468. 91. Lu H, van Zijl PCM. A review of the development of Vascular-Space-Occupancy (VASO) fMRI. NeuroImage 2012; 62: 736–742. 92. Donahue MJ, Sideso E, MacIntosh BJ, et al. Absolute arterial cerebral blood volume quantification using inflow vascular-space-occupancy with dynamic subtraction magnetic resonance imaging. Journal of Cerebral Blood Flow and Metabolism 2010; 30: 1329–1342. 93. Crone C. The Permeability of Capillaries in Various Organs as Determined by Use of the ‘Indicator Diffusion’ Method. Acta Physiol Scand 1963; 58: 292–305. 94. Vestergaard MB, Iversen HK, Simonsen SA, et al. Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease. Journal of Cerebral Blood Flow and Metabolism 2023; 43: 460–475. 95. Østergaard L, Jespersen SN, Engedahl T, et al. Capillary Dysfunction: Its Detection and Causative Role in Dementias and Stroke. Current Neurology and Neuroscience Reports; 15. Epub ahead of print 1 June 2015. DOI: 10.1007/s11910015-0557-x. 96. Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during wholebrain radiotherapy for brain metastases (RTOG 0933): A phase II multiinstitutional trial. Journal of Clinical Oncology 2014; 32: 3810–3816. 97. Brown PD, Gondi V, Pugh S, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: Phase III trial NRG oncology CC001. Journal of Clinical Oncology 2020; 38: 1019–1029. 98. Cialdella F, Bruil DE, van der Boog A, et al. Investigating the Relationship Between Radiotherapy Dose on the neurogenic niches and Overall Survival in NSCLC Brain Metastases. Epub ahead of print 2022. DOI: 10.1101/2023.05.10.23289385. 99. Artegiani B, Calegari F. Age-related cognitive decline: Can neural stem cells help us? Aging 2012; 4: 176–186.
RkJQdWJsaXNoZXIy MTk4NDMw